Three versions of the KPMP logo: transparent background, white background, and a mono (white) with transparent background.
Three versions of the KPMP logo icon: transparent background, white background, and a mono (white) with transparent background.
KPMP Overview (abbreviated)
This slide deck provides an abbreviated, high-level overview of the project. It is meant for audiences that need a shorter, more summarized presentation.
ASN KIDNEY WEEK Presentations
Presentations given by the KPMP consortium at the American Society of Nephrologists Kidney Week conferences.
Patient Engagement in Action
Richard Knight, the current President of the American Association of Kidney Patients (AAKP) and co-chair of our community engagement working group (CEWG), discussing the impact of the CEWG on this project, with an emphasis on the specific influence from our patient representatives.
How Can Precision Medicine Advance Nephrology
Dr. Robert Star, Director, Kidney, Urologic, and Hematologic Diseases at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) spoke about how precision medicine can advance nephrology.
Charting a New Course to Define Chronic and Acute Kidney Diseases
Dr. Krzysztof Kiryluk took the stage to discuss charting a new course to define chronic and acute kidney diseases. He explained some of the problems with the current approaches to define these diseases, reviewed some of the available alternatives, and showed how these approaches informed the development of the KPMP clinical protocol and study design.
A Glimpse of the Future: Precision Kidney Pathology
Dr. Ulysses Balis shows a glimpse of the future, demonstrating how the adoption of digital pathology and the integration of machine learning can influence the development and extend the impact of the KPMP’s kidney tissue atlas.
A Kidney Tissue Atlas to Guide Patients, Providers and Scientists
Dr. Laura Mariani walks the session attendees through several potential uses that are envisioned for the atlas, emphasizing the various functionality needed to support our different user communities – including patients, providers, and researcher scientists.